drugset / Trial / NCT04314986

Multiple Ascending Dose Study of AR882 in Healthy Adult Male Volunteers

NCT04314986

Phase 1 Completed 30 enrolled Arthrosi Therapeutics
RandomizedSequentialTriple-blindTreatment

Summary

A study to assess multiple ascending doses of AR882 in healthy adult males.

Timeline

Start
2019-06-28
Primary completion
2019-09-18
Completion
2019-09-18

Drugs

EvaluationDrugModalityDoseRoute
Subject AR882 Unknown

Indications

No indication recorded.